Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments (Q34026748)

30 July 2017

1 reference

title

Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments (English)

1 reference

30 July 2017

1 reference

Ariel Miller

1

1 reference

30 July 2017

Hillel Pratt

series ordinal

2

1 reference

30 July 2017

Randolph B Schiffer

series ordinal

3

1 reference

30 July 2017

publication date

3 May 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

1077-1088

1 reference

Review of pseudobulbar affect including a novel and potential therapy

30 July 2017

cites work

1 reference

Pathological laughing and crying : epidemiology, pathophysiology and treatment

21 January 2018

1 reference

Pathologic laughter and crying in ALS: a search for their origin

21 January 2018

1 reference

Mirtazapine treatment for pathological laughing and crying after stroke

21 January 2018

1 reference

An investigation of the psychiatric aspects of disseminated sclerosis

21 January 2018

1 reference

Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis

21 January 2018

1 reference

Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease.

21 January 2018

1 reference

Inappropriate crying and laughing in Parkinson disease and movement disorders

21 January 2018

1 reference

Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

21 January 2018

1 reference

Prevalence and clinical correlates of pathological affective display in Alzheimer's disease

21 January 2018

1 reference

Pathological laughter and crying in patients with closed traumatic brain injury

21 January 2018

1 reference

Pathological laughing and crying following traumatic brain injury.

21 January 2018

1 reference

Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases.

21 January 2018

1 reference

The neuropsychiatry of pathologic affect: an approach to evaluation and treatment

21 January 2018

1 reference

Treatment of pathologic laughing and weeping with amitriptyline

21 January 2018

1 reference

Involuntary emotional expression disorder (IEED) in Parkinson's disease

21 January 2018

1 reference

Psychological associations with emotionalism after stroke

21 January 2018

1 reference

Fluoxetine improves emotional incontinence

21 January 2018

1 reference

Citalopram for post-stroke pathological crying

21 January 2018

1 reference

Fluoxetine as a treatment for post-stroke emotionalism

21 January 2018

1 reference

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

21 January 2018

1 reference

Pathological laughter and crying: a link to the cerebellum

21 January 2018

1 reference

Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.

21 January 2018

1 reference

Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect.

21 January 2018

1 reference

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

21 January 2018

1 reference

Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect

21 January 2018

1 reference

Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission

21 January 2018

1 reference

Cerebellar tumour presenting with pathological laughter and gelastic syncope

21 January 2018

1 reference

Exaggerated crying and tremor with a cerebellar cyst.

21 January 2018

1 reference

Pontine infarction due to basilar artery stenosis presenting as pathological laughter

21 January 2018

1 reference

Stimulus-induced pathologic laughter due to basilar artery dissection

21 January 2018

1 reference

Pathological laughter as an unusual manifestation of acute stroke.

21 January 2018

1 reference

Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm

21 January 2018

1 reference

The primate cortico-cerebellar system: anatomy and function

21 January 2018

1 reference

Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing

21 January 2018

1 reference

The neuropsychiatry of the cerebellum - insights from the clinic

21 January 2018

1 reference

The cerebellar cognitive affective syndrome

21 January 2018

1 reference

Pathological laughter and crying in patients with multiple system atrophy-cerebellar type

21 January 2018

1 reference

Different responses of rat cerebellar Purkinje cells and Golgi cells evoked by widespread convergent sensory inputs

21 January 2018

1 reference

Dynamics of fast and slow inhibition from cerebellar golgi cells allow flexible control of synaptic integration

21 January 2018

1 reference

Characteristics of responses of Golgi cells and mossy fibers to eye saccades and saccadic adaptation recorded from the posterior vermis of the cerebellum.

21 January 2018

1 reference

The cerebellar microcircuit as an adaptive filter: experimental and computational evidence

21 January 2018

1 reference

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder

21 January 2018

1 reference

Pathologic laughter after unilateral stroke.

21 January 2018

1 reference

Duloxetine for pathological laughing and crying

21 January 2018

1 reference

Paroxetine versus citalopram treatment of pathological crying after brain injury.

21 January 2018

1 reference

Sertraline in stroke-associated lability of mood

21 January 2018

1 reference

Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study

21 January 2018

1 reference

Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect

21 January 2018

1 reference

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.

21 January 2018

1 reference

Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers

21 January 2018

1 reference

Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus

21 January 2018

1 reference

The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities

21 January 2018

1 reference

Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect

21 January 2018

1 reference

A self report measure of affective lability

21 January 2018

1 reference

Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients.

21 January 2018

1 reference

Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.11.68

1 reference

30 July 2017

1 reference